Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) has received a consensus rating of "Moderate Buy" from the twenty-one research firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and sixteen have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $613.10.
A number of research firms have issued reports on ISRG. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Truist Financial increased their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Finally, Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th.
Get Our Latest Stock Analysis on ISRG
Insider Transactions at Intuitive Surgical
In other news, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company's stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 over the last three months. 0.90% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Intuitive Surgical
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP grew its holdings in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 17 shares during the period. Onefund LLC boosted its position in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares in the last quarter. AlphaCore Capital LLC grew its stake in shares of Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC increased its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Finally, Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.
Intuitive Surgical Trading Down 0.1 %
ISRG traded down $0.78 during trading on Friday, hitting $591.01. 1,441,016 shares of the company traded hands, compared to its average volume of 1,716,563. The company has a market cap of $210.51 billion, a PE ratio of 92.20, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The stock's 50-day simple moving average is $566.43 and its two-hundred day simple moving average is $526.49.
About Intuitive Surgical
(
Get Free ReportIntuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.